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Summary 
T  cell activation by antigen/MHC  induces  the expression :of several genes critical to  the im- 
mune  response,  including  interleukin-2.  T  cells from  mice  deficient  for  the  NF-KB  family 
member c-tel cannot activate IL-2 gene expression.  However, mutating the NF-KB site in the 
IL-2 promoter has only moderate effects.  To investigate additional ways c-Rel could regulate 
IL-2 gene expression,  we determined whether c-rel overexpression could increase the activity 
of  other  transcription  factors  involved  in  IL-2  promoter  regulation:  NF-AT,  Oct/OAP 
(ARRE-1),  and AP-I.  In Jurkat TAg cells, overexpression of c-tkel increased AP-1  activation 
-'-'17-fold. Moreover, AP-1  activity stimulated by anti-TCR. Abs or PMA/ionomycin was fur- 
ther increased by c-Rel overexpression, c-lLel overexpression did not affect NF-AT or ARRE-1 
activity. Additionally,  overexpression of c-Rel activated the nonconsensus  AP-1  site from the 
IL-2 promoter (NF-IL-2B), although to a lesser extent, approximately sixfold. AP-1  activation 
required both the DNA binding and transactivation domains of c-lLel. Our results may provide 
an explanation for the effect on IL-2 gene activation in c-re/--deficient mice. 
T 
he secretion  of IL-2 by activated T  cells is an impor- 
tant step in the initiation of an immune response. The 
primary regulation of IL-2 expression is at the level of tran- 
scription.  The IL-2 promoter has been extensively charac- 
terized  (for  a  review,  see  references  1-3),  and  contains 
binding sites for several transcription factors, including nu- 
clear factor  of activated T  cells  (NF-AT) 1,  NF-KB,  AP-1, 
and octamer-binding proteins.  The exact nature  of the in- 
terplay between  these  different  transcription factors in  the 
induction  of  IL-2  expression  is  unknown.  Mutagenesis 
studies have demonstrated varying relative contributions of 
different  sites within the  IL-2 promoter  (4).  Mutating the 
AP-1  site  (NF-IL-2B)  decreased  promoter  expression  to 
11% of normal while mutating the distal NF-AT site (NF- 
IL-2E)  only  decreased  IL-2  promoter  activity  to  31%  of 
normal.  These  suggested that more  than  one  site  contrib- 
utes to IL-2 promoter activity. Consistent with this idea, if 
both the octamer sites are disrupted  (NF-IL-2A,  NF-IL-2D) 
or both the distal and proximal NF-AT sites are disrupted, 
IL-2 promoter activity is effectively abolished (5-7). 
Interestingly, many of the transcription factors that regu- 
late IL-2 gene expression appear to interact at multiple sites 
~Abbreviations used in this paper: Iuc, luciferase; NF-AT, nuclear factor of 
activated  T  cells; Oct, Octamer; OAP, octamer-associated protein; 
CD28R_E, CD28 response element; GST, glutathione-S transferase. 
withinthe IL-2 promoter.  For example, AP-1  family mem- 
bers can directly bind at. the AP-1  site (NF-IL-2B)  and are 
also capable of binding at:the NF-AT (8, 9) and at AR.R£-I 
(10)  sites in combination with NF-AT  and octamer-bind- 
ing proteins.  However,  mice  deficient in  c-los  (11),  c-jun 
(12), NF-KBp50  (3,  13),  Oct-2 (3,  14), or NF-ATp  (15,  16) 
have no defects in IL-2 gene transcription. Of course, these 
transcription  factors  are  members  of  large  families;  the 
knockouts  examined  may  not  include  the  critical  family 
member  required  for  IL-2  gene  expression  or  functional 
redundancy  within  each  family  may  compensate  for  the 
loss  of one  member.  Consistent  with  this  latter  proposal, 
when  AP-1  activity  is  disrupted,  not  by  homologous  re- 
combination but by overexpression of a dominant negative 
c-jun, which can presumably block the activity of many AP-1 
components  (jun/fos  family members),  IL-2  gene  expres- 
sion is eliminated (17). Similarly, overexpression of a dom- 
inant negative NF-ATc can also block IL-2 gene induction 
(18).  However,  unlike  knockouts  of  other  transcription 
factors, a disruption of the c-Rel gene alone is sufficient to 
eliminate IL-2 gene expression (19). 
c-Rel  is  a  member  of the  larger  NF-KB  family,  which 
includes  p65  (RelA)  and p50  (NF-vd31)  (for  reviews,  see 
references  20-22).  NF-KB family members all recognize  a 
similar decameric  motif (initially identified  as  the  KB  ele- 
ment in the K-light chain gene intronic enhancer; 23), bind 
DNA as either homo- or heterodimers, and contain a simi- 
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domain,  the  rel  homology  domain.  In  the  c-tel-deficient 
mice, although T  cell development is normal, mature T  cells 
fail to proliferate in response to mitogenic stimuli, such as 
Con A  and anti-CD3/anti-CD28  (19).  c-tel  -/-  T  cells also 
fail to produce IL-2 upon stimulation with Con A  or anti- 
CD3/anti-CD28,  although  other  cytokines  such  as  IL-5, 
TNF-0~, and IFN-',/are affected to a lesser degree (24). The 
proliferative defect  can be  rescued by addition of exoge- 
nous  IL-2. Therefore,  it appears that one  critical defect in 
c-tel deficient T  cells is the block in IL-2 gene expression. 
However, the mode of c-lKel action on the IL-2 promoter 
is not clear, but it is unlikely to be mediated by the NF-KB 
site  in  the  IL-2  promoter.  Mutation  of the  NF-KI3  (NF- 
IL-2C)  site had  only a  moderate  effect on  IL-2 promoter 
activity, to 20% of normal (1,  25). Additionally, the NF-KB 
family members  that bind to  this site in activated T  cells 
have  been  shown  to  be  either  p50  homodimers  (26)  or 
p50/p65  heterodimers  (27),  and do  not  appear to  contain 
c-lKel. Expression of both p50  and p65  is normal in c-tel- 
deficient mice. Therefore, it is unlikely that this NF-KB site 
in  the  IL-2 promoter mediates  the  defect  observed in  the 
c-tel-deficient  mice.  It is not  clear whether  the  CD281KE 
may mediate the  effect of c-R.el on  IL-2 gene regulation; 
there is conflicting evidence on the role of NF-KI3 in binding 
and  activating transcription from  the  CD28RE  (reviewed 
in references 28,  29).  Therefore, the loss of c-tel might af- 
fect other elements involved in IL-2 gene regulation. 
NF-KB p65  overexpression has been shown  to upregu- 
late AP-1 activity (30), and it is possible that c-lKel has sim- 
ilar effects. We have examined the effect ofc-Rel overexpres- 
sion on NF-AT, AP-1, and A1KRE-1  (Oct/OAP) activity. 
c-Rel dramatically increased activity from a consensus AP-1 
reporter  gene,  ~17-fold.  Additional increases  were  seen 
when c-Rel overexpression was combined with either anti- 
TC1K or PMA/ionomycin stimulation. However, only min- 
imal effects ofc-Rel overexpression on NF-AT or ARR.E-1 
reporters were observed, even though both these elements 
contain AP-1 sites, albeit nonconsensus. When the isolated 
AP-1  site from  either the  distal NF-AT  or A1K1KE-1  sites 
was examined, minimal effects of c-lKel overexpression was 
observed. It is probable that these sites cannot act indepen- 
dently and require cooperative binding of either NF-AT or 
octamer-binding factors. Overexpression of c-Kel also in- 
creased  activity from  a  reporter  containing  the  noncon- 
sensus AP-1  site  (NF-IL-2B) from the  IL-2 promoter,  al- 
though  to  a  lesser  degree  than  using  a  consensus  AP-1 
reporter,  approximately sixfold,  c-Rel activation of AP-1 
required both its DNA  binding and transcriptional activa- 
tion domains.  Our results may provide an  explanation for 
the lack of IL-2 expression in c-rel-deficient  mice. 
Materials  and Methods 
Plasmids.  The  expression plasmids  pCMV4,  pCMV4  p65, 
pCMV4 c-rel 1-307, and pCMV4 c-rel 187-587 were previously 
described (31). Reporter constructs were generated by multimer- 
izing oligos into  the  SalI site of the  reporter pAODLO  (a gift 
from Dr. B. Starr and Dr. K. Yamamoto). All reporter constructs 
were sequenced to verify number and orientation of inserted oli- 
gos. 4×ARRE luc contains four copies of the AR1KE-1 site from 
the IL-2 promoter in the reverse orientation using the following 
oligos: 
5'-TCGAGTTTGAAAATATGTGTAATATGTAAAACATG-3' 
3'-CAAACTTTTATACACATTATACATTTTGTACAGCT-5' 
4×AP-1 luc contains four copies of the consensus AP-1 site from 
the metallothienein promoter in the reverse orientation using the 
following oligos: 
5'-TCGAGTGACTCAGCGCG-3' 
3'-CACTGAGTCGCGCAGCT-5' 
3×NF-AT luc  contains  three  copies of the  distal NF-AT site 
from the IL-2 promoter in the forward orientation using the fol- 
lowing oligos: 
5 '-TCGAGGGAGGAAAA CTGTTTCATACA- 
GAAGGCGTG-3' 
3'-CCCTCCTTTTTGACAAAGTATGTCTTCCG- 
CACAGCT-5' 
3×NF-KB luc contains three copies of the NF-KB site from the 
IL-2 receptor o~ promoter in the reverse orientation using the fol- 
lowing oligos: 
5'-TCGAGACGGCAGGGGAATCTCCCTCTCCG-3' 
3'-CTGCCGTCCCCTTAGAGGGAGAGGCAGCT-5' 
5×AP-I(NF-AT) contains five copies of the AP-1 site from the 
distal NF-AT site of the IL-2 promoter in the reverse orientation 
using the following oligos: 
5'-TCGAGAACTGTTTCATACG-3' 
3'-CTTGACAAAGTATGCAGCT-5' 
4×AP-I(A1K1KE)  contains four copies of the AP-1 site from the 
A1K1KE-1 site of the IL-2 promoter in the reverse orientation us- 
ing the following oligos: 
5'-TCGAGATATGTGTAATATG-3' 
3'-CTATACACATTATACAGCT-5' 
4×AP-I(NF-IL-2B) contains four copies of the AP-1/NF-IL-2B 
site from the IL-2 promoter, three in the reverse orientation, and 
one in the forward orientation, using the following oligos: 
5'-TCGACAAAGAGTCATCAG-3' 
3'-GTTTCTCAGTAGTCAGCT-5' 
The site-directed mutants of c-rel, RxxR_xR., and KKK were cre- 
ated using a two-step PC1K-based  mutagenesis using the proof- 
reading Pwo polymerase (Boehringer Mannheim, Indianapolis,  IN). 
These  mutations  recreate  specific  site-directed mutations  that 
were originally generated in v-rel by Kumar et al. (32). The mu- 
tant RxxlkxlK changes 1K19 to A, 1K22 to A, and 1K24 to A. The 
mutant KKK changes Klll  to N, Kl12 to Q, and Kl13 to Q. 
After PC1K, the resulting mutants were sequenced to verify that 
the desired changes and no others had occurred. The oligos used 
to generate the mutations were as follows. 
To generate 1KxxRxlK: 
5'-GGCGGGAATGGCTTTTGCATACAAATGTGAAGG- 
GCG-3' 
3'-TAACTTGTTGGGTCCGTCCGCCCTTACCGAAAA- 
CGTA-5' 
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Figure  1.  Jurkat TAg  cells 
were transfected with 20 I.tg of 
either  (A)  4XAP-1 luc, (/3) 
3×NF-AT luc, (C)  3×NF-KB 
luc, or (D) 4XARRE luc and 40 
lag  of  either control vector 
D  pCDNA3  or  expression con- 
structs for p65 or c-rel. After 2 d, 
il  4xARRE luc  10  s live cells (~1/50 of the total 
cells from each transfection) was 
examined for luciferase activity. 
The results represent the average 
"~15]  of  three independent transfec- 
tions. Within  each experiment, 
the fold activation  was calculated 
for each construct relative to the 
luciferase activity  of the construct 
transfected with pCDNA3 alone. 
Error bars reflect the standard er- 
ror of the mean. Note that the 
pCDNA3 p65  c-rel  scale is different in (C). 
To generate KKK: 
5'-TGAACCAACAAGAAGTAAAAGAAGCTATT-3' 
3'-CCCATAAGCTACACACTTGGTTGTTCT-5' 
Cell Culture, Transfections, and Stimulations.  Jurkat TAg cells (pro- 
vided by Dr.  G. Crabtree)  were grown in RPMI supplemented 
with 10% fetal calf serum. The total amount ofDNA transfected 
within each experiment was kept constant by addition of the vec- 
tor pCDNA3 where appropriate.  1 ×  107 Jurkat TAg cells were 
transfected in a total volume of 0.4 ml in RPMI (without fetal calf 
serum)  by  electroporation  using a  BioRad  Gene Pulser Electro- 
porator  set at 250 V, 960 p+F. 2 d after transfection (40-48  h), the 
number of live cells within each sample were counted by Trypan 
blue exclusion. Luceriferase  assays were performed in triplicate 
within each experiment using 1 ×  10  s live cells in a total volume 
of 90 btl. Typically, this represents  1/50 of the total live cells re- 
covered after  2  d.  Samples were stimulated,  where appropriate, 
for 6 h  with a  1:1,000  dilution of C305 ascites (anti-clonotypic 
Jurkat TCR) or a combination of 50 ng/ml PMA and 1 DM iono- 
mycin (Calbiochem Novabiochem, San Diego, CA). All transfec- 
tions were done on three separate occasions, and the results rep- 
resent the  average  of three  independent transfections,  with the 
error bars representing the standard error from the mean. 
Luciferase Assays.  To the 90-t*1 cell sample  (containing 1  × 
105 live cells), 10 ~1 of cell harvest buffer containing 10% Triton 
X-100, 4 mM DTT, and 200 mM NaPO4, pH 7.8, and 100 I*l of 
assay buffer containing 200 mM NaPO4, pH 7.8, 20 mM MgC12, 
and 10 mM ATP was added.  Luciferase activity was measured af- 
ter luciferin addition either manually or in a  microplate lumi- 
nometer. 
Results 
c-rel  Overexpression  Activates  AP-I,  but  Not  NF-AT  or 
ARRE-1  Reporter Constructs.  To determine whether c-Rel 
could regulate IL-2 gene expression by increasing the  ac- 
tivity  of transcription factors  involved in  IL-2  promoter 
regulation, c-Rel was overexpressed in transient transfection 
assays using Jurkat TAg cells in combination with reporter 
constructs containing NF-AT, ARRE-1 (Oct/OAP), AP-1, 
and  NF-KB  sites.  The  empty  vector  pCDNA3  was  in- 
cluded  as  a  negative  control.  The  related  NF-KB  family 
member p65 was also included to determine whether c-Rel 
and  p65  could  differentially regulate  these  reporter  con- 
structs. As shown in Fig. 1 A, c-Rel dramatically enhanced 
AP-1 reporter activity, ~17-fold greater than vector alone. 
This  upregulation was  in  the  absence  of any stimuli.  In 
contrast,  p65  overexpression had  a milder effect on AP-1 
reporter activity, enhancing it approximately fourfold. These 
results  are  consistent  with  previous  reports,  where  p65 
overexpression upregulated AP-1  reporter  activity by ap- 
proximately fivefold (30). Therefore, c-Rel was a more po- 
tent activator of AP-1 reporter activity than p65. However, 
p65 was a better activator of an NF-KB reporter (Fig. 1 C) 
with ~100-fold greater activity than c-Rel. In contrast with 
the dramatic effects ofc-Rel overexpression on AP-1 reporter 
activity, only minimal effects on NF-AT and ARRE-1 re- 
porter activity were observed (Fig.  1,  B  and D),  although 
these reporters could be activated by a combination of PMA 
and ionomycin (data not shown). In addition, p65 overex- 
pression did not affect NF-AT or ARRE-1 reporter activ- 
ity. Therefore, c-Rel overexpression had the most dramatic 
effect on upregulating AP-1 activity, as compared with other 
transcription factors involved in regulating IL-2 promoter 
activity. 
Stimulation  and c-Rel Overexpression Cooperate in AP- 1 Activa- 
tion.  To determine whether AP-1 reporter activation de- 
pended on the extent of c-Rel expression, we performed a 
dose response analysis. As shown in Fig. 2 A, activation of 
AP-1  activity  increased  proportionately  with  increasing 
amounts oftransfected c-Rel. Transfections using increasing 
amounts of p65 did not lead to a dose-dependent effect on 
AP-1 activity. Since AP-1 activity is also increased in stim- 
ulated T  cells, we examined the effects of c-Rel overexpres- 
sion on TCR or PMA/ionomycin-mediated  AP-1 activation. 
As shown in Fig. 2 B and 2  C, overexpression of c-Rel en- 
hanced AP-1  activation after stimulation with either anti- 
TCR  antibodies or with a combination of PMA and iono- 
mycin.  This  effect  appears  to  be  additive,  and  titratable 
across  c-Rel  concentrations. Overexpression of p65  does 
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Figure  2.  Jurkat TAg cells were transfected  with 20 Ixg of4XAP-1 luc 
and either 40 Ixg of control vector pCDNA3 or increasing amounts (5 Ixg, 
10  btg, or  20  Ixg) of p65  or  c-rel  expression  constructs.  In  all  cases, 
pcDNA3 was added where appropriate to standardize the total amount 
of DNA transfected  to 60  txg total per sample.  After 2 d,  105 live cells 
(~1/50 of the total cells from each transfection)  were left nnstimulated, 
or stimulated with either 1:1,000 dilution of C305 anti-TCR ascites or 50 
mg/ml PMA with 1 I~M ionomycin. After 6 h, the cells were examined 
for luciferase activity.  The results represent the average of three indepen- 
dent transfections.  The fold activation was  calculated  relative  to the lu- 
ciferase  activity  of unstimulated cells transfected  with pCDNA3  alone. 
Error bars reflect the standard error of the mean. Note that the scale is dif- 
ferent in each graph. 
not increase AP-1  activity in response  to  either anti-TCR 
antibodies or with PMA/ionomycin.  Therefore,  c-Rel  in- 
creases the amount  of AP-1  activity in the presence  or ab- 
sence of additional stimuli such as via the TCR  or pharma- 
cologic agents. 
Overexpression of c-Rel also Increases the Activity  from the AP-1 
Site of the IL-2 Promoter (NF-IL-2B).  As  described  above, 
even though c-P~el appears to be a potent activator of AP-1, 
c-Rel had little effect on either NF-AT  or ARRE  reporter 
constructs  (see Fig.  1).  However,  both the NF-AT  site and 
the  ARRE-1  site  contain  nonconsensus  binding  sites  for 
AP-1, and AP-1  has been demonstrated to bind to these sites 
after  T  cell  activation.  Additionally,  there  is  another non- 
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Figure  3.  (A) The sequence of the AP-1  sites from the distal NF-AT 
site, the ARIkE-1 site, and the NF-IL-2B site from the IL-2 promoter is 
compared with the consensus AP-1  sequence.  (B) Jurkat TAg cells were 
transfected  with 20 txg of either 4×AP-I(ARRE) luc,  5×AP-I(NF-AT) 
luc,  or  4×AP-I(NF-IL-2B)  luc  and  40  p,g  of either  control  vector 
pCDNA3 or expression  constructs for p65 or c-rel.  After 2 d,  1 × 105 live 
cells (~1/50 of the total cells from each transfection)  was examined for 
luciferase activity. The results represent the average of either two (4 X AP- 
I[NF-IL-2B]  luc)  or  three  (4×AP-I[NF-AT]  luc  or 4XAP-I[AP,  RE] 
luc) independent transfections.  Within each experiment, the fold activa- 
tion was calculated  for each construct relative  to the luciferase activity of 
the construct transfected with pCDNA3 alone. Error bars reflect the stan- 
dard error of the mean. 
consensus  AP-1  site  in  the  IL-2  promoter,  the  NF-IL-2B 
site. To examine the effects ofc-Rel  overexpression on AP-1 
sites  from  the  IL-2  promoter  specifically,  reporter  con- 
structs containing only the AP-1  sites from either the distal 
NF-AT  site,  the  ARRE-1  site,  and  the  NF-IL-2B  AP-1 
site  were  created.  A  comparison  of  these  AP-1  sites  is 
shown in Fig.  3  A.  As shown in Fig.  3  B,  the activation of 
c-Re]  on  the  nonconsensus  NF-IL-2B  AP-1  reporter  was 
significant but less than observed with the  consensus AP-1 
reporter  (see  Fig.  1  A),  6-fold  as  compared  with  17-fold, 
respectively.  However,  although c-Rel mediated activation 
on  the  nonconsensus  NF-IL-2B  AP-1  reporter  is  weaker 
than on a  consensus AP-1  reporter,  it is still greater than the 
effects of p65  overexpression on a  consensus AP-1  reporter 
(see  Fig.  1  A;  30).  This  suggests  that one  way  c-Rel  may 
regulate  IL-2  gene  expression  is  through  the  NF-IL-2B 
AP-1  site. p65  overexpression had minimal effects on NF- 
IL-2B  AP-1  reporter  activity.  Only  minor  effects  are  ob- 
served by c-Rel or p65  overexpression on either of report- 
ers constructed with the nonconsensus AP-1  sites from the 
distal  NF-AT  or  ARRE-1  sites.  It  should  be  noted  that 
these nonconsensus AP-1  elements may not function with- 
out the adjacent NF-AT  or Octamer  sites.  Indeed,  AP-1  is 
unable to bind to  the distal NF-AT  site in the absence  of 
NF-AT  protein  (33).  Therefore,  these  AP-1  sites  from 
NF-AT  and  ARRE-1  may  not  function  as  independent 
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Figure  4.  (A) Shown schematically are various deletion mutants and 
site-directed mutants of c-rel relative to wild-type. The lighter NH2-ter- 
minal half of c-rel represents the rel domain, which is involved in DNA 
binding and dimerization. The darker COOH-terminal half of c-rel con- 
tains the transactivation domains. The X marks the placement of the mu- 
tated residues  within c-rel. (B) Jurkat TAg cells  were tramfected  with 20 }*g 
of4×AP-1 luc and 40 ~g of either control vector pCDNA3 or different 
expression constructs for wild-type or mutant c-rel. After 2 d, 1  × 10  s live 
cells (~1/50 of the total cells from each transfection) was examined for 
luciferase activity. The results represent the average of three independent 
transfections. Within each experiment, the fold activation was calculated 
for each construct relative to the luciferase activity of4×AP-1 luc trans- 
fected with pCDNA3  alone. Error bars reflect the standard error of the 
mean. 
AP-1  sites, which  may reflect the lack of activation by ei- 
ther c-Rel or p65 overexpression. These results suggest one 
way  through  which  c-Rel  may  regulate  IL-2  gene  tran- 
scription, through activation of the NF-IL-2B AP-1 site. 
Both the DNA Binding Domain and the Transactivation Do- 
mains of c-Rel Are Required for AP-1 Activation.  To  deter- 
mine which domains of c-Rel were responsible for upreg- 
ulating AP-1  reporter activity, various c-Rel mutants were 
generated  (shown schematically in  Fig. 4  A).  c-Rel 1-307 
consists of only the Rel domain, which contains the DNA 
binding and  dimerization sequences  as well as the  nuclear 
localization signal but lacks all previously described activa- 
tion domains (31). c-Rel 187-587  has a deletion within the 
DNA binding domain of c-Rel, but contains the dimeriza- 
tion  domain, nuclear translocation signal, and transactivation 
domains  (31).  c-Rel RxxRxR  and  KKK  recreate  specific 
DNA  binding  mutants  that  were  originally described  by 
Kumar et al. (32) in v-Rel. The homologous residues within 
the  p50  tel  homology  domain  were  found  in  the  crystal 
structure to be specific DNA contact residues (34), suggest- 
ing that these mutations  eliminate DNA  binding by alter- 
ing direct interactions rather than by indirect structural per- 
turbations. As shown in Fig. 4  B, elimination of either the 
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DNA binding domain, by either deletion or specific muta- 
tion, or the transactivation domains abolished the ability of 
c-Rel to  increase AP-1  activity. Therefore,  both  of these 
domains are critical for the activation of AP-1 by c-Rel. 
Discussion 
We have demonstrated that c-Rel substantially upregulates 
activity of an AP-1 reporter. This effect is not observed with 
either an NF-AT or ARRE-1 reporter. Moreover, c-Rel can 
activate an  AP-1  reporter constructed  from  the  NF-IL-2B 
site of the IL-2 promoter. The activation of AP-1 by c-Rel 
required both the DNA binding and transactivation domains 
of c-Rel.  These  data  suggest  that  c-Rel is  not  increasing 
AP-1  reporter  activity by  functioning  as  a  coactivator.  If 
c-Rel functions  as a  coactivator,  one  would  expect to  be 
able to mutate the DNA binding domain of c-Rel and still 
increase AP-1 reporter activity when overexpressed. How- 
ever,  as shown  in  Fig. 4  B,  two  distinct site-directed mu- 
tants of c-Rel that specifically disrupted DNA binding did 
not  upregulate  activity from  an  AP-1  reporter.  Addition- 
ally, we attempted to determine whether c-Rel could bind 
directly to AP-1  family members bound to an AP-1 oligo- 
nucleotide in gel mobility shift assays. Using a recombinant 
GST-c-rel fusion protein, we were unable to demonstrate a 
shift  in  the  AP-1  complexes when  GST-c-rel  was  added 
(data not  shown).  These  data argue  against,  although  not 
eliminate, the possibility that c-rel is functioning as a coac- 
tivator to upregulate AP-1  activity. It is also possible that 
c-rel mediates the AP-1  activation indirectly, by increasing 
expression of a  cytokine or other soluble factor, which,  in 
turn,  upregulates AP-1  activity. However,  mixing experi- 
ments argue against this idea. Specifically,  Jurkat TAg cells, 
transfected either with 4XAP-1  luc or with a  c-rel expres- 
sion  vector,  were  mixed  together.  Upregulation  of AP-1 
activity would  have  implicated  a  soluble  factor  in  c-rel- 
mediated AP-1 activation. However, no activation of AP-1 
was  detected (data not shown).  Therefore,  it does not ap- 
pear that c-rel mediates AP-1 activation by functioning as a 
coactivator, by binding directly to  AP-1  sites,  or by pro- 
ducing a  cytokine or other soluble factor,  which,  in turn, 
feeds back to increase AP-1 activity. 
In  activated T  cells, AP-1  activity is  regulated by  two 
mechanisms:  levels of AP-1  family members  (fos/jun)  are 
transcriptionally upregulated and their relative activity is in- 
creased by phosphorylation (35).  Since c-rel is a  transcrip- 
tion  factor,  c-rel may upregulate AP-1  activity directly by 
increasing AP-1 protein levels through an increase in tran- 
scription of AP-1 family members. However, we were un- 
able  to  detect  either an  increase in  AP-1  levels using  gel 
mobility shift assays or an increase in the protein levels of 
fos/jun family members by Western blot analyses from c-Rel 
overexpressing transiently transfected Jurkat TAg cells (data 
not  shown).  This  may  be  due  to  limitations  within  our 
transient expression system.  Since we  are unable  to  detect 
AP-1 protein in transiently transfected cells, we also cannot 
examine  an  alternate  possibility in  which  c-rel  activates 
AP-1  through  increased phosphorylation,  c-rel and JNK1 have been reported to interact in vivo, although the func- 
tional significance of this interaction is not known (36). It is 
possible that c-rel could directly or indirectly activate JNK1 
to influence AP-1 reporter activity. The elucidation of the 
mechanism by which c-rel increases AP-1 activity will de- 
pend on the development of a stable, inducible c-rel over- 
expression system, which is currently under investigation. 
The  critical role  for  c-rel in  IL-2  gene  expression was 
discovered using mice deficient for c-tel.  Interestingly, this 
phenotype  of mature  T  cells in the  c-tel-deficient  mouse, 
characterized by an inability to produce IL-2 and prolifer- 
ate  in  response  to  stimuli,  closely resembles  what  is  ob- 
served in  anergic T  cell clones  (reviewed in  37-38).  The 
failure of anergic T  cell clones to produce IL-2 is due to an 
inability to upregulate AP-1  activity after stimulation (39), 
demonstrating the  essential role of AP-1  in  IL-2 gene  in- 
duction. Our results show that c-rel overexpression leads to 
increased AP-1  activity.  Therefore,  the  failure  of T  cells 
from  c-tel deficient mice to produce  IL-2 may be  due,  at 
least in  part,  to  a  secondary decrease  in  AP-1  activation. 
The  activation of AP-1  by c-rel provides one  mechanism 
by which c-rel functions to regulate IL-2 gene expression. 
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